Literature DB >> 15454892

Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital.

Stephen J Wilson1, Cynthia J Knipe, Madeline J Zieger, Kari M Gabehart, Joyce E Goodman, Helen M Volk, Rajiv Sood.   

Abstract

We conducted a case-control study to determine the attributable direct costs of multidrug-resistant Acinetobacter baumannii (MDRAB) in the burn unit of a public teaching hospital. The mean total hospital cost of patients who acquired MDRAB was 98,575 dollars higher than that of control patients who had identical burn severity of illness indices ( P <.01). These data should help infection control practitioners and others determine the cost-effectiveness of specific interventions designed to control this emerging nosocomial pathogen.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15454892     DOI： 10.1016/j.ajic.2004.02.008

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  26 in total

1.  Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm.

Authors:  Nikhil D Thawal; Ajinkya B Yele; Praveen K Sahu; Balu A Chopade
Journal:  Curr Microbiol       Date:  2012-04-26       Impact factor: 2.188

Review 2.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 3.  Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Authors:  Christian G Giske; Dominique L Monnet; Otto Cars; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

4.  Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.

Authors:  Tara Reddy; Teena Chopra; Dror Marchaim; Jason M Pogue; George Alangaden; Hossein Salimnia; Dina Boikov; Shiri Navon-Venezia; Robert Akins; Philip Selman; Sorabh Dhar; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

5.  Attributable Cost and Length of Stay Associated with Nosocomial Gram-Negative Bacterial Cultures.

Authors:  Richard E Nelson; Vanessa W Stevens; Makoto Jones; Karim Khader; Marin L Schweizer; Eli N Perencevich; Michael A Rubin; Matthew H Samore
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

6.  Clinicians' knowledge, attitudes, and practices regarding infections with multidrug-resistant gram-negative bacilli in intensive care units.

Authors:  Juyan Julia Zhou; Sameer J Patel; Haomiao Jia; Scott A Weisenberg; E Yoko Furuya; Christine J Kubin; Luis Alba; Kyu Rhee; Lisa Saiman
Journal:  Infect Control Hosp Epidemiol       Date:  2013-01-24       Impact factor: 3.254

7.  Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.

Authors:  Chen Niu; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

8.  Isolation and characterization of Salmonella enterica in day-old ducklings in Egypt.

Authors:  Kamelia M Osman; Sherif H Marouf; Tara R Zolnikov; Nayerah AlAtfeehy
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

9.  Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

Authors:  Jesús Rodríguez-Baño; Lola García; Encarnación Ramírez; Luis Martínez-Martínez; Miguel A Muniain; Felipe Fernández-Cuenca; Margarita Beltrán; Juan Gálvez; Jose M Rodríguez; Carmen Velasco; Concepción Morillo; Federico Perez; Andrea Endimiani; Robert A Bonomo; Alvaro Pascual
Journal:  Am J Infect Control       Date:  2009-05-19       Impact factor: 2.918

10.  Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.

Authors:  Patrick D Mauldin; Cassandra D Salgado; Ida Solhøj Hansen; Darshana T Durup; John A Bosso
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.